Health ❯ Healthcare ❯ Medical Treatments

Oncology

Lung Cancer Glioma Multiple Myeloma Chronic Myeloid Leukemia Small Cell Lung Cancer Desmoid Tumors Colorectal Cancer Acute Myeloid Leukemia CAR T-cell Therapy Bladder Cancer Chemotherapy Melanoma Immunotherapy Breast Cancer Melanoma Therapy Prostate Cancer Non-Small Cell Lung Cancer Brain Tumors

FDA Clears Enhertu-Perjeta Combo for First-Line HER2-Positive Metastatic Breast Cancer

The decision follows phase 3 results showing a roughly 14-month median progression-free survival advantage over the THP regimen.

FDA Approves Perioperative Keytruda–Padcev for Cisplatin‑Ineligible Muscle‑Invasive Bladder Cancer

FDA Approves Darzalex Faspro as First Therapy for High-Risk Smoldering Multiple Myeloma

FDA Approves Lurbinectedin Plus Atezolizumab for First-Line Maintenance in Extensive-Stage SCLC

European Commission Approves Voranigo for IDH-Mutant Grade 2 Glioma